Trends in Cardiovascular Medicine
Volume 15, Issue 5 , Pages 185-189 , July 2005

Physiologic Growth and Pathologic Genes in Cardiac Development and Cardiomyopathy

  • Gerald W. Dorn II

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Gerald W. Dorn II, Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, 231 Albert Sabin Lane, Cincinnati, OH 45267-0542, USA. Tel.: (+1) 513-558-3065; fax: (+1) 513-558-3438.

References 

  1. Adams JW, Sakata Y, Davis MG, et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. U.S.A. 1998;95:10140–10145
  2. Akhter SA, Luttrell LM, Rockman HA, et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574–577
  3. Aronow BJ, Toyokawa T, Canning A, et al. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol. Genomics. 2001;6:19–28
  4. Chen G, Cizeau J, Vande VC, et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J. Biol. Chem. 1999;274:7–10
  5. Crow MT. Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ. Res. 2002;91:183–185
  6. D'Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. U.S.A. 1997;94:8121–8126
  7. De Windt LJ, Lim HW, Taigen T, et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ. Res. 2000;86:255–263
  8. Dorn GW, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc. Med. 1999;9:26–34
  9. Dorn GW, Tepe NM, Lorenz JN, et al. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc. Natl. Acad. Sci. U.S.A. 1999;96:6400–6405
  10. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ. Res. 2000;87:856–864
  11. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 1975;56:56–64
  12. Hahn HS, Yussman MG, Toyokawa T, et al. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition. Circ. Res. 2002;91:741–748
  13. Hayakawa Y, Chandra M, Miao W, et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation. 2003;108:3036–3041
  14. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. U.S.A. 2002;99:12825–12830
  15. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 1996;28:1737–1746
  16. Minamino T, Yujiri T, Terada N, et al. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc. Natl. Acad. Sci. U.S.A. 2002;99:3866–3871
  17. Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J. Clin. Invest. 2005;115:518–526
  18. Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet activation in G alpha(q)-deficient mice. Nature. 1997;389:183–186
  19. Offermanns S, Zhao LP, Gohla A, et al. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J. 1998;17:4304–4312
  20. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ. Res. 2002;91:226–231
  21. Rockman HA, Ross RS, Harris AN, et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 1991;88:8277–8281
  22. Sakata Y, Hoit BD, Liggett SB, et al. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation. 1998;97:1488–1495
  23. Sanbe A, Gulick J, Hanks MC, et al. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ. Res. 2003;92:609–616
  24. Simon MI, Strathmann MP, Gautam N. Diversity of G proteins in signal transduction. Science. 1991;252:802–808
  25. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 2003;43:381–411
  26. Sohal DS, Nghiem M, Crackower MA, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 2001;89:20–25
  27. Song Q, Schmidt AG, Hahn HS, et al. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J. Clin. Invest. 2003;111:859–867
  28. Subramaniam A, Jones WK, Gulick J, et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 1991;266:24613–24620
  29. Syed F, Odley A, Hahn HS, et al. Physiological growth synergizes with pathological genes in experimental cardiomyopathy. Circ. Res. 2004;95:1200–1206
  30. Webster WS. Teratogen update: congenital rubella. Teratology. 1998;58:13–23
  31. Wettschureck N, Rutten H, Zywietz A, et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 2001;7:1236–1240
  32. Wilkie TM, Scherle PA, Strathmann MP, et al. Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. Proc. Natl. Acad. Sci. U.S.A. 1991;88:10049–10053
  33. Wu G, Toyokawa T, Hahn H, Dorn GW. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Gaq. J. Biol. Chem. 2000;275:29927–29930
  34. Yussman MG, Toyokawa T, Odley A, et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat. Med. 2002;8:725–730

 This study was supported by the National Heart, Lung, and Blood Institute, Washington, DC, USA, P50 HL77101, P01 HL69779, and R01s HL59888 and HL58010.

PII: S1050-1738(05)00063-0

doi: 10.1016/j.tcm.2005.05.009

Trends in Cardiovascular Medicine
Volume 15, Issue 5 , Pages 185-189 , July 2005

Article Tools

* Image Usage & Resolution